Send to

Choose Destination
See comment in PubMed Commons below
Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):866-9.

Role of granulocyte colony-stimulating factor in the treatment of mucormycosis.

Author information

  • 1Department of Oncology, Cukurova University, Faculty of Medicine, Balcalì-Adana, Turkey.


Several problems in the management of life-threatening mucormycosis remain unresolved, necessitating new methods of management. Four patients with histopathologically proven rhinocerebral mucormycosis were treated with high cumulative doses of granulocyte colony-stimulating factor (G-CSF). All had multiple predisposing factors for mucormycosis, particularly leukemia and neutropenia. Two patients refractory to fluconazole therapy were treated with liposomal amphotericin B. The improvement in clinical manifestations was closely related to neutrophil recovery, and all patients were alive at the end of therapy. In addition to surgical debridement and antifungal therapy, G-CSF seems to have played a role in their survival.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk